SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: D.Right who wrote (1092)2/3/1998 12:17:00 PM
From: MulhollandDrive  Respond to of 2173
 
D. Right, heard an analyst on CNBC, (sorry did not get name) stating that bio-tech is ripe for a move right now. The big drug firms stock prices are hitting all time highs, so acquisitions are certainly getting lots of consideration. bp



To: D.Right who wrote (1092)2/3/1998 3:14:00 PM
From: Don S.Boller  Read Replies (1) | Respond to of 2173
 
D.Right: I AM A TYPE 2 DIABETIC so am interested in any
product that can simplify my life...as an "adult onset or Type2
I am not insulin dependent. I use control with one drug -
Glucophage - a strict diet (which basically eliminates carbos.).
Therefore, I am curious about AMLN and others...but have
yet to buy a share (see my previous posts). FWIW.
Best,
Don



To: D.Right who wrote (1092)2/3/1998 5:03:00 PM
From: Harry Ehrlich  Respond to of 2173
 
Thanks for the medical info; makes sense to me. Chartwise, looks like we're taking a bit of a rest. Slight dip today.

Harry


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News